These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25686905)

  • 1. Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.
    Morikawa Y; Kezuka C; Endo S; Ikari A; Soda M; Yamamura K; Toyooka N; El-Kabbani O; Hara A; Matsunaga T
    Chem Biol Interact; 2015 Mar; 230():30-9. PubMed ID: 25686905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
    Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
    Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
    Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
    Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
    Matsunaga T; Morikawa Y; Haga M; Endo S; Soda M; Yamamura K; El-Kabbani O; Tajima K; Ikari A; Hara A
    Toxicol Appl Pharmacol; 2014 Jul; 278(2):180-9. PubMed ID: 24813866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome.
    Matsunaga T; Yamaji Y; Tomokuni T; Morita H; Morikawa Y; Suzuki A; Yonezawa A; Endo S; Ikari A; Iguchi K; El-Kabbani O; Tajima K; Hara A
    Free Radic Res; 2014 Nov; 48(11):1371-85. PubMed ID: 25156503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers.
    Matsunaga T; Kezuka C; Morikawa Y; Suzuki A; Endo S; Iguchi K; Miura T; Nishinaka T; Terada T; El-Kabbani O; Hara A; Ikari A
    Biol Pharm Bull; 2015; 38(9):1309-19. PubMed ID: 26328486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
    Yao H; Hu J; Shao Y; Shah Q; Zheng S
    Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance.
    Matsunaga T; Saito H; Endo S; Iguchi K; Soda M; El-Kabbani O; Hara A; Ikari A
    Free Radic Res; 2016 Dec; 50(12):1296-1308. PubMed ID: 27629782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the aldo-keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms.
    Matsunaga T; Yamane Y; Iida K; Endo S; Banno Y; El-Kabbani O; Hara A
    Anticancer Drugs; 2011 Jun; 22(5):402-8. PubMed ID: 21317765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance].
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2.
    Nishinaka T; Miura T; Okumura M; Nakao F; Nakamura H; Terada T
    Chem Biol Interact; 2011 May; 191(1-3):185-91. PubMed ID: 21277289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
    Chewchuk S; Guo B; Parissenti AM
    PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
    Zhang W; Li H; Yang Y; Liao J; Yang GY
    Cancer Lett; 2014 Dec; 355(2):273-80. PubMed ID: 25304374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
    Ebert B; Kisiela M; Wsól V; Maser E
    Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
    Takemura M; Endo S; Matsunaga T; Soda M; Zhao HT; El-Kabbani O; Tajima K; Iinuma M; Hara A
    J Nat Prod; 2011 May; 74(5):1201-6. PubMed ID: 21561086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
    Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
    Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
    Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
    Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10-inhibitory Selaginella tamariscina extract and amentoflavone decrease the growth of A549 human lung cancer cells in vitro and in vivo.
    Jung YJ; Lee EH; Lee CG; Rhee KJ; Jung WS; Choi Y; Pan CH; Kang K
    J Ethnopharmacol; 2017 Apr; 202():78-84. PubMed ID: 28286104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
    Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
    Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.